PharmaOnco™ H22 Cancer Cell Line (CAT#: ITS-0523-LX91)

Datasheet

Datasheet

Overview
Specification

Applications

in vitro and in vivo assay

Organism

Mouse

Tissue

Liver

Disease

Hepatocellular carcinoma

Morphology

Lymphoblast-like

Biosafety Level

BSL-2

Tumorigenicity

Tumorigenic

Split Ratio

1:2 to 1:4

Medium Renewal

2 to 3 times per week

Related Products

PharmaOnco™ Human SNB-19 Tumor Cell Line (CAT#: IOC-ZP057)
PharmaOnco™ HEK293T-Tg(Human Gαqi5//Human CXCR4 Receptor) Stable Cell Line, Single Clone (CAT#: ITS-0624-HMM121)
PharmaOnco™ Mouse B-CAG-luc B16-F10 Reporter Tumor Cell Line (CAT#: IOC-ZP022)
PharmaOnco™ Jurkat-Tg(Human LAG3)-NFAT Luc Reporter Cell Line, Single Clone (CAT#: ITS-0822-HMM177)
PharmaOnco™ HEK293T-Tg(Human Gα16//Human CRF2 Receptor) Stable Cell Line, Single Clone (CAT#: ITS-0624-HMM141)
PharmaOnco™ HEK293T-Tg(Rat A2B Receptor) Stable Cell Line, Single Clone (CAT#: ITS-0624-HMM11)
PharmaOnco™ Jurkat-Tg(Human CTLA4)-IL-2 Reporter Cell Line, Single Clone (CAT#: ITS-0822-HMM135)
PharmaOnco™ HEK293-Tg(Mouse NOD1) Stable Cell Line, Cell Pool/Single Clone (CAT#: ITS-0822-HMM88)

For Research Use Only | Not For Clinical Use

Online Inquiry

Copyright © 2026 Creative Biolabs. All Rights Reserved.

ISO 9001 Certified - Creative Biolabs Quality Management System.

Close

Thanksgiving

Thanksgiving